FDA Further Limits Johnson & Johnson Covid Vaccine
Johnson & & Johnson was eclipsed long ago by Pfizer and Moderna in the country’s vaccination campaign; federal officials have said the mRNA vaccines produced by those business are both safer and more efficient. In a declaration, Johnson & & Johnson said the F.D.A.’s action reflected the already-known risk of the side impact, not new data on the rate at which it occurs. The number of deaths associated to the condition triggered by the Johnson & & Johnson’s vaccine does not appear to have increased much, if at all. About 17 million Americans have actually now gotten one dosage of Johnson & & Johnson’s vaccine, and another 1.5 million have actually gotten a booster dose, according to the C.D.C.’s data.
Johnson & & Johnson was eclipsed long back by Pfizer and Moderna in the nation’s vaccination campaign; federal authorities have said the mRNA vaccines produced by those companies are both more secure and more effective. The number of deaths attributed to the condition set off by the Johnson & & Johnson’s vaccine does not appear to have actually increased much, if at all. About 17 million Americans have now gotten one dosage of Johnson & & Johnson’s vaccine, and another 1.5 million have gotten a booster dosage, according to the C.D.C.’s information.